Growth Metrics

Rockwell Medical (RMTI) Return on Capital Employed (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Return on Capital Employed for 15 consecutive years, with 0.11% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Return on Capital Employed fell 12.0% year-over-year to 0.11%, compared with a TTM value of 0.11% through Sep 2025, down 12.0%, and an annual FY2024 reading of 0.01%, up 22.0% over the prior year.
  • Return on Capital Employed was 0.11% for Q3 2025 at Rockwell Medical, down from 0.03% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.01% in Q3 2024 and bottomed at 1.27% in Q1 2022.
  • Average Return on Capital Employed over 5 years is 0.43%, with a median of 0.41% recorded in 2023.
  • The sharpest move saw Return on Capital Employed tumbled -83bps in 2022, then soared 87bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.93% in 2021, then surged by 45bps to 0.51% in 2022, then surged by 64bps to 0.19% in 2023, then skyrocketed by 107bps to 0.01% in 2024, then tumbled by -867bps to 0.11% in 2025.
  • Business Quant data shows Return on Capital Employed for RMTI at 0.11% in Q3 2025, 0.03% in Q2 2025, and 0.01% in Q1 2025.